Factors influencing progression of keratoconus 2 years after corneal collagen cross-linking in pediatric patients


Sarac O., Caglayan M., Cakmak H. B., ÇAĞIL N.

Cornea, cilt.35, sa.12, ss.1503-1507, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 12
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1097/ico.0000000000001051
  • Dergi Adı: Cornea
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1503-1507
  • Anahtar Kelimeler: corneal collagen cross-linking, pediatric keratoconus, progression, predictive factors, OUTCOMES, CHILDREN
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

© 2016 Wolters Kluwer Health, Inc.Purpose: To assess the preoperative patient characteristics that may predict outcomes of keratoconus 2 years after corneal collagen cross-linking (CXL) in pediatric patients with keratoconus. Methods: This retrospective study included 72 eyes of 52 consecutive patients with keratoconus under the age of 18 with 2-year follow-up after CXL. Subgroup analysis and cutoff values were determined as per age (<14 and ≥14 years), sex, baseline uncorrected and corrected distance visual acuities (UCVA, CDVA; <0.8 and ≥0.8 logMAR), topographic cone location (central and paracentral), maximum keratometry (K-max, <54 and ≥54 diopters), and corneal thickness at the thinnest point (thCT) (<450 and ≥450 m) to evaluate the associations between preoperative patient characteristics and outcomes of CXL treatment in terms of K-max. Postoperative progression in K-max was defined as steepening of 1.0 diopter or more. Results: Average age of patients was 14.8 ± 2.2 (9-17) years. After 2 years, the mean UCVA significantly improved and the mean thCT significantly decreased in all patients (P 0.023, P < 0.001, respectively). The K-max in patients with paracentral cones and/or with thCT less than 450 m were more likely to progress (cone location: P 0.023, odds ratio 3.21, 95% confidence interval, 1.17-8.72; thCT: P 0.008, odds ratio 4.54, 95% confidence interval, 1.46-14.14). Age, sex, baseline UCVA, CDVA, and K-max did not present any significant effect on progression of CXL after treatment (P > 0.05 for all variables). Conclusions: In pediatric patients with keratoconus, cone location and the baseline thinnest corneal thickness seem to affect the success rate of CXL treatment after 2-year follow-up.